Although the pfmdr1 NFSDD haplotype was found in only four isolates, it has been 36 associated with artemether-lumefantrine treatment failure in Africa. LDR-FMA allows large-37 scale assessment of resistance-associated SNPs. Our findings reflect previous heavy 4-38 aminoquinoline/sulfadoxine-pyrimethamine use in PNG. Since artemether-lumefantrine and 39 piperaquine-dihydroartemisinin will become first-and second-line treatment, respectively, 40
INTRODUCTION
conditions described in Table 1 . Target sequences in the 3' and 5' fragments of the pfmdr1 121 gene encode for alleles at codons 86, 184 and 1034, 1042, 1246 respectively. DNA samples 122 from the laboratory-adapted P. falciparum strains HB3, Dd2, K1, 3D7, and 7G8 were 123 included as haplotype controls for pfmdr1 polymorphisms. 124
125
To evaluate amplification efficiency, 5 µl PCR products were mixed with loading dye buffer 126 and loaded on 2% agarose I gels. For a 96-well gel, electrophoresis was performed at 290 V 127 for 30 min. The gel was subsequently stained in SYBR Gold (Molecular Probes, Eugene, 128
Oreg.) diluted 1:10,000 in 1X TBE buffer and DNA products visualised on a Storm 860 129 imaging system coupled with Image-Quant (version 5.2) software (Molecular Dynamics, CA). analysis of parasite drug resistance-associated SNPs in dhfr, dhps and pfcrt were as described 135 previously (4, 26). The technique was adapted to include 10 different pfmdr1 allelic variants 136 reported to confer resistance to CQ (16, 17), amino-alcohols and quinine (6, 33, 37) . 137
138
Following PCR amplification of the target sequences carrying drug resistance-associated 139 pfmdr1 SNPs, the products were subjected to LDR in which allele-specific upstream primers 140 ligate to conserved sequence downstream primers. The LDR upstream allele-specific primers 141 have unique 5'TAG sequences of 24 nucleotides that enable subsequent SNP identification. 142
Downstream conserved sequence oligonucleotides were 5'phosphorylated and 3'biotinylated 143 (Table 2) Fluorescence signals were first normalized to a mean of 10,000 and SD 1,000 arbitrary units 170 for each codon by subtracting the calculated mean from every signal within the 171 corresponding codon, then multiplying by 1,000/codon-specific SD, and finally addingstrains with known genotypes, thus providing controls within each SNP assay. Once adjusted, 174 codon-specific cut-points that applied to all control strains were derived with a value that 175 predicted the highest number of true positives as a conservative cut-point for distinguishing 176 positive signals from background fluorescence. 177
178
A cut-point of >9600 had 97.5%, 98.8% and 98.6% accuracy for predicting true positive 179 alleles for codons 540, 581 and 613 in the pfdhps gene in control strains. The >9600 cut-point 180 also applied to codons 1042 and 1246 in the pfmdr1 gene, while >9800 accurately predicted 181 known alleles at codon 86 in the pfmdr1 gene, codons 51, 59, 108 and 164 in the pfdhfr gene, 182 and in the CVMNK, SVMNT, and CVIET pfcrt haplotypes. A threshold of >10,000 applied 183 to pfmdr1 codons 184 and 1034. By reversing the normalisation process, the cut-points were 184 made specific to each drug resistance marker. A similar approach that uses polar-co-ordinates 185 has also been used to determine thresholds for the LDR-FMA system (9). 186 187 Mixed strain infections can be identified when fluorescence signals from both alleles (i.e. 188 wild type and mutated) from the same codon occur above calculated cut-points. Previous 189 experiments have shown that strain-specific allele fluorescence signals are in direct 190
proportion to the ratio of the parasite strain densities within the sample (4). We have also 191 assayed day 28 and day 42 post-treatment blood samples from patients from the clinical trial 192 (21) that were parasite negative by both microscopy and PCR and found very low 193 fluorescence signals (<200). These observations indicate that multiple P. falciparum strains In 402 samples with microscopy-confirmed P. falciparum, the Plasmodium species LDR-217 FMA identified 28 patients with P. vivax co-infections and 13 with P. malariae co-infections. and thresholds used to determine the presence of an allele are shown in Table 4 . 227 228 Overall, 9 mutant alleles were detected. These were at pfmdr1 codons N86Y (91%), Y184F 229 (2%), N1042D (2%), D1246Y (4%), pfcrt codons C72S and K76T (both 92%), pfdhfr codons 230 C59R (93%), S108N (95%) and pfdhps codon K540E (1.5%) (Figure 1) . We found the pfcrt 231 haplotype SVMNT to be at fixation in the sample (92%), with only 7% of P. falciparum 232 strains retaining the CQ-sensitive haplotype CVMNK. Two children were infected with 233 mixed strains carrying CVIET and SVMNT mutations. The majority of the P. falciparum 234 isolates carried the CQ resistance-associated YYSND (93%) haplotype of the pfmdr1 gene 235 (Figure 2 and had a LPF, whilst the other three had an ACPR. Table 5 
